This site is intended for health professionals only

At the heart of general practice since 1960

pul jul aug2020 cover 80x101px
Read the latest issue online

Independents' Day

Paper of the Day - Women 'less protected by aspirin'

An analysis of clinical data suggests that aspirin does not significantly reduce the risk that women will suffer heart attacks.

A review of data from 23 trials of more than 113,000 people prescribed aspirin for primary and secondary prevention of myocardial infarction (MI) found that more than a quarter (27%) of the variation in the non-fatal MI results could be accounted for by gender.

Aspirin conferred more protective benefit on men than women. Trials that recruited predominantly men demonstrated the largest risk reduction in non-fatal MI (38% lower than placebo; relative risk = 0.62).

Trials that contained predominately women failed to demonstrate a significant risk reduction in non-fatal MI.

Dr Don Sin, from the department of medicine at the University of British Columbia in Canada, concluded that:

‘Gender accounts for a substantial proportion of the variability in the efficacy of aspirin in reducing MI rates across these trials, and [the data] supports the notion that women might be less responsive to aspirin than men.'

BMC Medicine 2007, 5:29

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say